OPTIRAY 350 Ioversol 74% w/v injection Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 350 ioversol 74% w/v injection

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections; trometamol hydrochloride; trometamol - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

OPTIRAY 350 Ioversol 74% w/v injection Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 350 ioversol 74% w/v injection

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the vardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

OPTIRAY 350 Ioversol 74% w/v injection Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 350 ioversol 74% w/v injection

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 320 ultraject ioversol 50.8g/75ml injection syringe

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; sodium hydroxide; water for injections - other conditions: protect from secondary x-rays. optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography and venography. opitray may be used for intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiocardiography, contrast enhanced computed tomographic imaging of the head and body and intravenous excretory urography.

OPTIRAY 350 Ioversol 92.6g/125mL injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 350 ioversol 92.6g/125ml injection syringe

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

OPTIRAY 350 Ioversol 74.1g/100mL injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 350 ioversol 74.1g/100ml injection syringe

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections; trometamol hydrochloride - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

OPTIRAY 240 Ioversol 25.45 g/50 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 240 ioversol 25.45 g/50 ml injection vial

guerbet australia pty ltd - ioversol, quantity: 509 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretory urography.

OPTIRAY 320 Ioversol 84.75 g/125 mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 84.75 g/125 ml injection

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; hydrochloric acid; sodium hydroxide - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiograpy, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

OPTIRAY 320 Ioversol 33.9 g/50 mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 33.9 g/50 ml injection

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; hydrochloric acid; sodium hydroxide - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiograpy, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

OPTIRAY 240 Ioversol 63.63 g/125 mL injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 240 ioversol 63.63 g/125 ml injection syringe

guerbet australia pty ltd - ioversol, quantity: 509 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; hydrochloric acid; sodium hydroxide - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretory urography.